Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0027 USD | +10.20% | +8.00% | -68.97% |
2023 | Endonovo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
2023 | Endonovo Therapeutics, Inc 's Sofpulse® Secures Taiwan FDA Approval | CI |
- Stock Market
- Equities
- ENDV Stock
- News Endonovo Therapeutics, Inc.
- MarketScreener Strategies